SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-006614
Filing Date
2020-11-16
Accepted
2020-11-16 12:56:25
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 348201
2 CERTIFICATION nbio_ex311.htm EX-31.1 9629
3 CERTIFICATION nbio_ex312.htm EX-31.2 9626
4 CERTIFICATION nbio_ex321.htm EX-32.1 3890
5 CERTIFICATION nbio_ex322.htm EX-32.2 4060
  Complete submission text file 0001477932-20-006614.txt   2519908

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20200930.xml EX-101.INS 346020
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20200930.xsd EX-101.SCH 47066
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20200930_lab.xml EX-101.LAB 237053
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20200930_cal.xml EX-101.CAL 31717
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20200930_pre.xml EX-101.PRE 217883
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20200930_def.xml EX-101.DEF 137604
Mailing Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121
Business Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 201315077
SIC: 2834 Pharmaceutical Preparations